391 related articles for article (PubMed ID: 24819502)
41. Functional characterization of a CDKN1B mutation in a Sardinian kindred with multiple endocrine neoplasia type 4 (MEN4).
Pardi E; Mariotti S; Pellegata NS; Benfini K; Borsari S; Saponaro F; Torregrossa L; Cappai A; Satta C; Mastinu M; Marcocci C; Cetani F
Endocr Connect; 2015 Mar; 4(1):1-8. PubMed ID: 25416039
[TBL] [Abstract][Full Text] [Related]
42. Clinical Profile and Mutations Associated with Multiple Endocrine Neoplasia-Type1 (MEN1) and Their First-Degree Relatives at Risk of Developing MEN1: A Prospective Study.
Shyamasunder AH; Pai R; Ramamoorthy H; Sakhti D; Manipadam MT; Kapoor N; Paul TV; Jebasingh F; Thomas N; Abraham DT; Paul MJ; Chacko AG; Prabhu K; Rajaratnam S
Horm Metab Res; 2021 Apr; 53(4):245-256. PubMed ID: 33853118
[TBL] [Abstract][Full Text] [Related]
43. Genetic analysis of parathyroid and pancreatic tumors in a patient with multiple endocrine neoplasia type 1 using whole-exome sequencing.
Kim BY; Park MH; Woo HM; Jo HY; Kim JH; Choi HJ; Koo SK
BMC Med Genet; 2017 Oct; 18(1):106. PubMed ID: 28969599
[TBL] [Abstract][Full Text] [Related]
44. A germline c.1546dupC MEN1 mutation in an MEN1 family: A case report.
Cho YY; Chung YJ
Medicine (Baltimore); 2021 Jun; 100(25):e26382. PubMed ID: 34160414
[TBL] [Abstract][Full Text] [Related]
45. Mutational analysis of p27 (CDKN1B) and p18 (CDKN2C) in sporadic pancreatic endocrine tumors argues against tumor-suppressor function.
Lindberg D; Akerström G; Westin G
Neoplasia; 2007 Jul; 9(7):533-5. PubMed ID: 17710155
[TBL] [Abstract][Full Text] [Related]
46. Mutational analysis of CDKN1B, a candidate tumor-suppressor gene, in refractory secondary/tertiary hyperparathyroidism.
Lauter KB; Arnold A
Kidney Int; 2008 May; 73(10):1137-40. PubMed ID: 18288099
[TBL] [Abstract][Full Text] [Related]
47. Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders.
Giraud S; Zhang CX; Serova-Sinilnikova O; Wautot V; Salandre J; Buisson N; Waterlot C; Bauters C; Porchet N; Aubert JP; Emy P; Cadiot G; Delemer B; Chabre O; Niccoli P; Leprat F; Duron F; Emperauger B; Cougard P; Goudet P; Sarfati E; Riou JP; Guichard S; Rodier M; Meyrier A; Caron P; Vantyghem MC; Assayag M; Peix JL; Pugeat M; Rohmer V; Vallotton M; Lenoir G; Gaudray P; Proye C; Conte-Devolx B; Chanson P; Shugart YY; Goldgar D; Murat A; Calender A
Am J Hum Genet; 1998 Aug; 63(2):455-67. PubMed ID: 9683585
[TBL] [Abstract][Full Text] [Related]
48. Germline CDKN1B Loss-of-Function Variants Cause Pediatric Cushing's Disease With or Without an MEN4 Phenotype.
Chasseloup F; Pankratz N; Lane J; Faucz FR; Keil MF; Chittiboina P; Kay DM; Hussein Tayeb T; Stratakis CA; Mills JL; Hernández-Ramírez LC
J Clin Endocrinol Metab; 2020 Jun; 105(6):1983-2005. PubMed ID: 32232325
[TBL] [Abstract][Full Text] [Related]
49. Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).
Thakker RV
Mol Cell Endocrinol; 2014 Apr; 386(1-2):2-15. PubMed ID: 23933118
[TBL] [Abstract][Full Text] [Related]
50. Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics.
Scarpelli D; D'Aloiso L; Arturi F; Scillitani A; Presta I; Bisceglia M; Cristofaro C; Russo D; Filetti S
J Endocrinol Invest; 2004 Dec; 27(11):1015-21. PubMed ID: 15754732
[TBL] [Abstract][Full Text] [Related]
51. Somatic mutation of the MEN1 gene in parathyroid tumours.
Heppner C; Kester MB; Agarwal SK; Debelenko LV; Emmert-Buck MR; Guru SC; Manickam P; Olufemi SE; Skarulis MC; Doppman JL; Alexander RH; Kim YS; Saggar SK; Lubensky IA; Zhuang Z; Liotta LA; Chandrasekharappa SC; Collins FS; Spiegel AM; Burns AL; Marx SJ
Nat Genet; 1997 Aug; 16(4):375-8. PubMed ID: 9241276
[TBL] [Abstract][Full Text] [Related]
52. Two novel mutations in the MEN1 gene in subjects with multiple endocrine neoplasia-1.
Ozturk M; Chiu CY; Akdeniz N; Jenq SF; Chang SC; Hsa CY; Jap TS
J Endocrinol Invest; 2006 Jun; 29(6):523-7. PubMed ID: 16840830
[TBL] [Abstract][Full Text] [Related]
53. Identification of a novel frameshift c.930delG MEN1 germline mutation (p.Glu273LysfsTer7) in a sporadic case of multiple endocrine neoplasia type 1: A case report.
Naruse H; Umemura H; Nakayama T
Mol Med Rep; 2020 Dec; 22(6):5423-5427. PubMed ID: 33173995
[TBL] [Abstract][Full Text] [Related]
54. A novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype.
Occhi G; Regazzo D; Trivellin G; Boaretto F; Ciato D; Bobisse S; Ferasin S; Cetani F; Pardi E; Korbonits M; Pellegata NS; Sidarovich V; Quattrone A; Opocher G; Mantero F; Scaroni C
PLoS Genet; 2013 Mar; 9(3):e1003350. PubMed ID: 23555276
[TBL] [Abstract][Full Text] [Related]
55. Familial isolated primary hyperparathyroidism--a multiple endocrine neoplasia type 1 variant?
Miedlich S; Lohmann T; Schneyer U; Lamesch P; Paschke R
Eur J Endocrinol; 2001 Aug; 145(2):155-60. PubMed ID: 11454510
[TBL] [Abstract][Full Text] [Related]
56. Haploinsufficient and predominant expression of multiple endocrine neoplasia type 1 (MEN1)-related genes, MLL, p27Kip1 and p18Ink4C in endocrine organs.
Taguchi R; Yamada M; Horiguchi K; Tomaru T; Ozawa A; Shibusawa N; Hashimoto K; Okada S; Satoh T; Mori M
Biochem Biophys Res Commun; 2011 Nov; 415(2):378-83. PubMed ID: 22037578
[TBL] [Abstract][Full Text] [Related]
57. Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism.
Miedlich S; Krohn K; Lamesch P; Müller A; Paschke R
Eur J Endocrinol; 2000 Jul; 143(1):47-54. PubMed ID: 10870030
[TBL] [Abstract][Full Text] [Related]
58. Multiple endocrine neoplasia type 4 (MEN4): a thorough update on the latest and least known men syndrome.
Ruggeri RM; Benevento E; De Cicco F; Grossrubatscher EM; Hasballa I; Tarsitano MG; Centello R; Isidori AM; Colao A; Pellegata NS; Faggiano A
Endocrine; 2023 Dec; 82(3):480-490. PubMed ID: 37632635
[TBL] [Abstract][Full Text] [Related]
59. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
Pardi E; Marcocci C; Borsari S; Saponaro F; Torregrossa L; Tancredi M; Raspini B; Basolo F; Cetani F
J Clin Endocrinol Metab; 2013 Jul; 98(7):2800-10. PubMed ID: 23633209
[TBL] [Abstract][Full Text] [Related]
60. Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, and CDKN2C in sporadic parathyroid adenomas.
Costa-Guda J; Soong CP; Parekh VI; Agarwal SK; Arnold A
Horm Cancer; 2013 Oct; 4(5):301-7. PubMed ID: 23715670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
